Compound Detail
CHEMBL4763264
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Basic Information
| ChEMBL ID | CHEMBL4763264 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PEWZDBOBEGIBSD-QSFXBCCZSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
500.6
MW (Da)
1.94
ALogP
6
HBA
4
HBD
138.6
PSA (Ų)
0.37
QED
1
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 4.5
IC50 1 meas. best 7.46
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 35.0 | nM | 7.46 | Reversible inhibition of SARS coronavirus Urbani 3CL protease(9985 to 10902) usi... | 33054210 |
| SARS-CoV | EC50 | = | 32000.0 | nM | 4.5 | Antiviral activity against SARS COV-1 infected in monkey vero 76 cells assessed ... | 33054210 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33054210 | 10.1021/acs.jmedchem.0c01063 | SARS-CoV | 1 |
| 33054210 | 10.1021/acs.jmedchem.0c01063 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine